Health
Oxford vaccine stimulates broad antibody and T cell functions – Medical Xpress
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing…
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
These findings are reported in two papers, both released in the peer-reviewed journal Nature Medicine.
Previous studies have shown that in order to develop any vaccine against SARS-CoV-2 coronavirus,…
-
Noosa News22 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General23 hours agoWaste from Perth set to be trucked out to York after WA minister approves landfill site
-
Noosa News23 hours agoShattered families demand justice after Wieambilla killers not deemed terrorists
-
General6 hours agoGymnastics club in Berwick shuts down following child safety complaint